Matthew P. Wilson - Concepedia

Author

Matthew P. Wilson

VIB-KU Leuven Center for Cancer Biology ORCID

Also Known As

Matthew P Wilson, Matthew P. Wilson, Matthew Wilson

Publications

921

Citations

H-Index

Concepts

All Affiliations

VIB-KU Leuven Center for Cancer Biology KU Leuven University College London Université de Lille Unité de Glycobiologie Structurale et Fonctionnelle

About

Matthew P. Wilson is an author at VIB-KU Leuven Center for Cancer Biology specializing in medicine, molecular biology, and glycobiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	199
2	Cell Biology	2	2	148
3	Natural Sciences	1	1	37
4	Biochemistry	1	1	37
5	Immunology	1	1	12

Matthew P. Wilson

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans Timothy A. Scott, Leonor M. Quintaneiro, Povilas Norvaišas, Cell	2017	248
Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy Niklas Darín, Emma Reid, Laurence Prunetti, The American Journal of Human Genetics Molecular NeuroscienceGeneticsMedicineCell BiologyCause Vitamin-b6-dependent Epilepsy	2016	136
<i>PDXK</i> mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation Viorica Chelban, Matthew P. Wilson, Jodi Warman‐Chardon, Annals of Neurology	2019	72
N-glycosylation as a eukaryotic protective mechanism against protein aggregation Ramon Duran‐Romaña, Bert Houben, Matthias De Vleeschouwer, Science Advances Proteomic TechnologyProtein FunctionBiochemistryProtein AssemblyProtein Folding	2024	37
An LC–MS/MS-Based Method for the Quantification of Pyridox(am)ine 5′-Phosphate Oxidase Activity in Dried Blood Spots from Patients with Epilepsy Matthew P. Wilson, Emma Footitt, Apostolos Papandreou, Analytical Chemistry	2017	26
Quality and stability of extemporaneous pyridoxal phosphate preparations used in the treatment of paediatric epilepsy Abeer H. A. Mohamed-Ahmed, Matthew P. Wilson, Maedelyn Albuera, Journal of Pharmacy and Pharmacology	2017	23
A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis Matthew P. Wilson, Takfarinas Kentache, Charlotte R. Althoff, Cell	2024	23
Beyond genetics: Deciphering the impact of missense variants in <scp>CAD</scp> deficiency Francisco del Caño‐Ochoa, Bobby G. Ng, Antonio Rubio‐del‐Campo, Journal of Inherited Metabolic Disease	2023	16
Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings Matthew P. Wilson, Alejandro Garanto, Filippo Pinto e Vairo, The American Journal of Human Genetics Rare DiseasesActive Site VariantsMendelian DisorderGenetic DisorderMedicine	2021	14
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking Matthew P. Wilson, Zoé Durin, Özlem Ünal, Human Molecular Genetics	2022	14

Page 1